Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Endometriosis

In brief

The purpose of this study is to determine whether Proellex is safe and effective for the treatment of symptomatic endometriosis.

Key facts

Study ID
NCT00556075
Run by
Repros Therapeutics Inc.
People needed
67
Starts
2007-11-01
Expected to finish
2009-07-01
Last updated by the study team
2014-08-25

Who can join

Age: 18 and older, up to 48. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.